1Bristow RE,Tomacruz RS,Armstrong DK,et al.Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era:a meta-analysis.J Clin Oncol,2002,20:1248 -1259.
3Magibay PM,Adams PB,Silveran MB,et al.Splenectomy as part of cytoreductive surgery in ovarian cancer.Gynecol Oncol,2006,102:369-374.
4Manci N.Bellati F.Muzii L,et al.Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence:surgical and survival data.Ann Surg Oncol,2006,13:1717-1723.
5Tran T,Davila JA,El-Serag HB.The epidemiology of malignant gastrointestinal stromal tumors:an analysis of 1,458 cases from 1992 to 2000.Am J Gastroenterol,2005,100:162-168.
7Mok Sc,Bell DA,Knapp KC,et al.Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.Cancer Res,1993,53(7):1489-1492.
8Shih IeM,Kurman RJ.Molecular pathogenesis of ovarian borderline tumors:new insights and old challenges.Clin Cancer Res,2005,11(20):7273-7279.
2Clark TG, Stewart ME, Altman DG, et al. A prognostic model for ovarian cancer. Br J Cancer, 2001,85:944-952.
3De Laurentiis M, De Plaeido S, Bianeo AR, et al. A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients. Clin Cancer Res, 1999, 5:4133-4139.
4Linasmita V, Pattaraarchachai J, Daengdeelert P. Prognostic factors for survival of epithelial ovarian cancer, lnt J Gynecol Obstet, 2004,85:66-69.
5Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gyneeol Oneol,1998, 69:103-108.
6Brinkhuis M, Meijer GA, Baak JP. An evaluation of prognostic factors in advanced ovarian cancer. Eur J Obstet Gynecol Reprod Biol, 1995, 63 : 115-124.
7Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol, 2002, 20: 1248-1259.
8Bristow RE, Montz FJ, Lagasse LD, et al. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol, 1999, 72:278-287.
